Artivila Biopharma
June 22, 2026
Theater 3
Type: Company Presentation
Focus Area:
Multiple Therapeutics
Artivila Biopharma is a leading clinical stage biotechnology company that focuses on empowering innovative drug discovery with an advanced AIDD+CADD drug discovery platform. With years of successful drug discovery experience and track record, we focus on autoimmune diseases, neurodegenerative diseases, and opportunistically cancers. Our strong innovative drug discovery capability has ensured the depth and high value of both First in Class and Best in Class project pipeline including a phase II ready asset.
Company HQ City:
Shenzhen
Company HQ State:
Guangdong Province
Company HQ Country:
China
Year Founded:
2018
Lead Product in Development:
ARD-885 has completed Phase-1 study with excellent PK/PD and safety. Phase 2 in preparation for RA & SLE patients
CEO
dniu@artivilatx.com
Development Phase of Lead Product
Phase II
When you expect your next catalyst update?
2026
Primary Speaker
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}